Objective: To analyze the physical manifestations and genetic features of 2 families segregating X-linked deafness, which is most commonly reported to be caused by mutations of the POU domain gene POU3F4 at the DFN3 locus.
proximately 530 kilobases; in the second family, a novel serine-to-leucine (S228L) amino acid mutation was identified in the POU-specific domain of POU3F4. Both the deletion and the missense mutation segregate with the clinical phenotype and are causally related to the deafness in these families.
Conclusions: Deafness related to the POU3F4 gene is associated with dilation of the internal auditory canal and a spectrum of other temporal bone anomalies that range in severity from mild to severe dysplasia of the cochlea and semicircular canals. The consequence of these anomalies is a congenital mixed hearing loss, the sensorineural component of which progresses over time. Affected males can also present with vestibular dysfunction that is associated with delayed developmental motor milestones. Intrafamilial variability occurs. Surg. 2005; 131:1057 -1063 C ONGENITAL DEAFNESS IS diagnosed in approximately 1 in every 1000 newborns, half of whom have inherited deafness that is most often autosomal recessive and nonsyndromic. The fractional contribution of X-linked deafness is estimated at 2%, which implies that X-linked deafness affects roughly 1 in every 50 000 newborn males. The Hereditary Hearing Loss Homepage 1 lists 6 X-linked nonsyndromic deafness loci (DFN2, DFN3, DFN4, DFN5, DFN6, and DFN8) and provides mapping data for 4 (DFN2, DFN3, DFN4, and DNF6), but in only 1 instance has the deafness-related gene been identified. Deafness at the DFN3 locus is caused by mutations in the coding sequence or deletions upstream of POU3F4.
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The gene POU3F4 (POU domain, class III, transcriptional factor 4) encodes a transcription factor with bipartite DNA-binding domains, a 75-amino acid POU-specific domain that is linked by 17 amino acids to a 63-amino acid homeobox domain. The latter is common among transcription factors and recognizes specific DNA sequence motifs while the former is unique to the POU gene family and strengthens the binding affinity to DNA. All POU3F4 deafness-causing missense mutations localize to 1 of these 2 DNA-binding domains while deletions affect a putative regulatory element located at least 400 kilobases (kb) upstream of the gene 2,3 ( Table 1 and Figure 1 ). In aggregate, these mutations account for about 40% of X-linked deafness.
Although the genes regulated by POU3F4 are unknown, the phenotypic consequence of absence of a functional POU3F4 protein is a range of temporal bone anomalies that make thin-cut computed tomography (CT) of the temporal bones an important diagnostic tool to determine whether mutation screening of POU3F4 is warranted in a male with presumed nonsyndromic deafness. The observed defects of the bony labyrinth are often classified as pseudo-Mondini stage II dysplasia. 9 Features include partial hypoplasia of the cochlea and dilation of the internal auditory canal, often with a fistulous communication between its lateral aspect and the basal turn of the cochlea. 10 Outward pressure of perilymphatic fluid on the oval window from within the vestibule hinders stapedial vibration, 11 and anomalies of the oval window and stapedial footplate also compromise ossicular chain mobility. 12 In aggregate, these anomalies result in a conductive component to POU3F4-related deafness. With time, the sensorineural component of the hearing loss progresses as a reflection of ongoing inner ear damage. Stapedectomy is contraindicated because the uncontrolled leak of perilympha (a perilymphatic "gusher") can severely compromise residual hearing and vestibular function.
In this article, we describe 2 extended families segregating X-linked deafness. Temporal bone CT of the proband from each family showed numerous defects of the bony labyrinth, raising the possibility of mutations in POU3F4. Mutation screening and deletion mapping of this gene were completed, confirming the diagnosis of deafness at the DFN3 locus. The clinical presentation of POU3F4-related deafness is reviewed as an aid to recognizing this type of nonsyndromic hearing loss. 
METHODS

SUBJECTS
The 2 families in this study were ascertained through genetics clinics at Southern Illinois University School of Medicine, Springfield (family 6190), and Children's Mercy Hospitals and Clinics, Kansas City, Mo (family 6270) ( Figure 2 and Figure 3 , respectively). Blood samples from probands were sent to the Molecular Otolaryngology Research Laboratories at The University of Iowa, Iowa City, for mutation screening. Family histories were obtained by means of a questionnaire and personal interviews. A complete physical examination, including audiometry, was performed on each proband. Audiograms also were obtained from additional family members interested in participating in this study. All persons who wished to participate in the study provided a blood sample. The University of Iowa Human Subjects Committee approved all procedures.
PREPARATION OF DNA
Samples of DNA were extracted from peripheral whole blood (approximately 10 mL) following established procedures. 13 Each polymerase chain reaction (PCR) was performed in a total volume of 10 µL with 1 µL of 10ϫ buffer, 0.33 µL of magnesium chloride, 0.15 µL of primer A, 0.15 µL of primer B, 0.4 µL of deoxynucleotide triphosphate, 0.04 µL of Taq polymerase, 1.5 µL of 20-ng/µL DNA, and 6.43 µL of water, hot-starting the reaction for 3 minutes at 95°C, followed by 35 cycles of denaturation for 30 seconds at 94°C, annealing for 30 seconds at 66°C, and extension for 30 seconds at 72°C, culminating in a 10-minute extension at 72°C after PCR.
DELETION MAPPING IN FAMILY 6190
Short tandem repeat polymorphisms were used to identify the approximate size of the deletion. Breakpoint mapping was completed using 29 primer pairs upstream of POU3F4, which generated amplimers spaced across 57 kb of genomic DNA at roughly equal intervals (a list of the primer pairs is available from the authors on request). Polymerase chain reaction was carried out as described in the preceding section, and products were resolved by means of gel electrophoresis and scored as present or absent. All PCRs were repeated at least twice.
MUTATION SCREENING IN FAMILY 6270
Mutation screening of the coding region of POU3F4 was completed using the primers listed in Table 2 . The PCR products were resolved by means of gel electrophoresis to ensure product amplification and sequenced using an automated sequencer (Applied Biosystems Model 3700; Applied Biosystems, Inc, Foster City, Calif). Data were analyzed using the Sequencer 4.2 program package (Gene Codes, Inc, Ann Arbor, Mich).
RESULTS
FAMILY 6190
Theprobandinfamily6190(6190-13)wasdiagnosedashaving congenital severe-to-profound hearing loss after auditory brainstem response testing (ABR) at 1 month of age; delayed latencies also suggested a conductive component to the loss. A temporal bone CT scan obtained 1 month later was consistent with incomplete partitioning of the cochlea and interpreted as pseudo-Mondini stage II dysplasia (Figure4).Visualreinforcementaudiometryatage7months gavefairlyreliableresponses,suggestingamoderate-to-severe hearing loss downsloping from 55 dB in the low frequencies to 80 dB in the high frequencies ( Figure 5A) .
The strong family history of deafness was consistent with X-linked inheritance (Figure 2) . A review of the medical reports indicated that the proband's great-great-uncle, 6190- 3, had experienced a perilymphatic gusher while undergoing surgery. The proband's first cousin once removed, 6190-11, was born at full term and failed his newborn hearing screen. Follow-up ABR at 1 month of age showed a bilateral absence of waveforms consistent with at least a severe hearing loss in both ears, and ABR results at 18 months of age were consistent with moderate-to-severe hearing loss. By age 4 years, hearing thresholds were recorded at 95 and 55 dB at 500 and 2000 Hz, respectively ( Figure 5B ).
The history of the proband's great-uncle, 6190-7, is particularly instructive. He was born with hearing loss, which was diagnosed as a severe mixed loss. At 6 years of age, he underwent an exploratory tympanotomy to correct the conductive component of his hearing loss. The attempted stapedectomy resulted in a perilymphatic gusher and, although his hearing deteriorated in the operated-on ear, hearing in the contralateral ear remained stable ( Figure 5C ). Computed tomography was never performed.
Female members of family 6190 did not have congenital hearing loss, although family members 6190-1 and 6190-2 both developed presbycusis in their seventh decade of life. Patient 6190-1 had intermittent difficulties with balance and vertigo.
FAMILY 6270
The proband in family 6270 (6270-3) presented with a history of chronic otitis media necessitating an adenotonsillectomy and myringotomies with the placement of pressure-equalizing tubes. Temporal bone CT at age 22 months showed bilateral dilation of the internal auditory canals and cochlear hypoplasia; the vestibule and semicircular canals appeared normal. Auditory brainstem response testing results at 2 years of age were consistent with a symmetrical, moderate low-frequency hearing loss that rose to a mild hearing loss in the mid to high frequencies. The thresholds to click stimuli were 50 and 45 dB in the right and left ears, respectively. Auditory steady-state responses indicated thresholds of 50 and 60 dB, and of 70 and 60 dB at 2000 and 4000 Hz in the right and left ears, respectively. Developmental motor milestones were slightly delayed, with sitting at age 7 to 8 months, crawling at 10 months, and walking at 16 months.
Family member 6270-1, the fraternal twin of 6270-2 and younger brother of 6270-3, was diagnosed as having bilateral mild-to-moderate sensorineural hearing loss at 11 months of age after ABR. Responses to click stimuli were 35 dB in the right ear and 45 dB in the left ear, with responses to 500-Hz tone bursts at 48 dB in both ears. Developmental motor milestones were delayed secondary to presumed vestibular dysfunction, with crawling first noted at age 11 months. By age 20 months, walking was still not possible. Temporal bone CT was not performed.
Family member 6270-7, the 6-year-old affected maternal cousin, had bilateral profound sensorineural hearing loss; developmental motor milestones were reported to be normal. The brother of 6270-7, 6270-8, had normal hearing.
MUTATION SCREENING
Family 6190 segregates a large deletion that includes POU3F4 and spans a region of approximately 650 kb. The deletion breakpoints are approximately 530 kb up- stream and approximately 127 kb downstream of POU3F4 (Figure 6) . Family 6270 segregates a cytosine-to-thymine transition that segregates with the deafness phenotype and predicts a novel missense mutation, S228L (Figure 3 ). This mutation lies within the POU-specific domain and generates a ConSeq score of 9 (range, 1 [low] to 9 [high]) (http://conseq.bioinfo.tau.ac.il/), consistent with a highly conserved and functionally important amino acid residue. 14 
COMMENT
Families 6270 and 6190 contribute to our understanding of DFN3 by presenting a novel missense mutation within the POU-specific domain of POU3F4 and a large deletion that includes the entire gene. From the clinical information these cases provide and the available reports of deafness at the DFN3 locus, there appears to be no obvious genotype-phenotype relation associated with POU3F4-related deafness with respect to defects of the bony labyrinth, vestibular dysfunction, the degree of sensorineural hearing loss, and the progression of hearing loss.
To date, 6 truncating and 11 nontruncating mutations have been reported in association with POU3F4-related deafness ( Table 3) . Included in the truncating groups are 5 nonsense mutations and a small deletion of 4 nucleotides that results in a frameshift mutation. The nontruncating mutations include 10 missense mutations and an inframe deletion of 2 amino acids. With many diseases, including deafness caused by mutations in the genes GJB2 and SLC26A4, phenotypic variability is seen when truncating and nontruncating mutations are compared, reflecting the presence of a translated protein with the latter group of mutations, which may have some, albeit minimal, residual activity. However, from the available clinical descriptions of POU3F4-related deafness, it is clear that no phenotypic-genotypic effect exists ( Table 4) .
The S228L change we identified in family 6270 is only the second POU-specific domain mutation reported thus far. In this family, intrafamilial variability in temporal bone anomalies and hearing thresholds is clearly evident. Although family members 6270-1 and 6270-3 have yet to experience progression of hearing loss, it is likely that both children will become profoundly deaf. This bleak prognosis reflects the observation made by Cremers and colleagues 4 that while the rate of progression of hearing loss can vary among individuals, all persons with POU3F4-related deafness ultimately have profound deafness at varying ages. The 3 affected males in family 6270 also have variable degrees of vestibular dysfunction.
The DFN3-related deafness in family 6190 is due to the deletion of the POU3F4 gene itself. Based on the 5Ј breakpoint location, the regulatory region of POU3F4 is unlikely to be affected ( Figure 6 ). Other families have been described that also segregate deletions of POU3F4; however, in most families in which a deletion is found, composite deletion mapping localizes a region approximately 900 kb upstream of POU3F4 as the site of a putative regulatory element. 7 In family 6190, the presence of a temporal bone CT scan for only 1 person precludes any comparisons; however, there is a large difference in the audiograms obtained from family members 6190-7, 6190-11, and 6190-13 ( Figure 5 ). findings in a male should raise suspicion for POU3F4-related deafness and, if the pedigree is consistent with X-linked inheritance, genetic testing can be considered. If a mutation in POU3F4 is identified, the chance for the couple to have an additional affected child is 25%, and their chance for having another affected male is 50%. 
